MYOV - Myovant Sciences GAAP EPS of -$0.63 misses by $0.09 revenue of $57.6M misses by $14.74M May, 10 2022 07:01 AM Myovant Sciences Ltd. Myovant Sciences press release (NYSE:MYOV): Q4 GAAP EPS of -$0.63 misses by $0.09. Revenue of $57.6M (+134.1% Y/Y) misses by $14.74M. Shares -1.03% PM. For further details see: Myovant Sciences GAAP EPS of -$0.63 misses by $0.09, revenue of $57.6M misses by $14.74M